Opendata, web and dolomites
H2020 projects about "orally"
The page lists 22 projects related to the topic "orally".
| # | |||
|---|---|---|---|
| 1 | VETBIOMAT | Advanced material for the regeneration of joints in veterinary medicine | 2015 |
| 2 | INTESTINANOS | Intestinal Lipoidal Nanostructures - A Lipid Bridge to Increased Drug Delivery | 2015 |
| 3 | POSTDATA | Poetry Standardization and Linked Open Data | 2016 |
| 4 | PIGYVAX | Making a yeast-based candidate vaccine against Porcine Epidemic Diarrhea Virus (PEDV) | 2016 |
| 5 | iCARE | MobIle health-Care system for monitoring toxicity and symptoms in cAncer patients ReceivingdiseasE-oriented therapy | 2016 |
| 6 | PFKFBLOCK | Translating fundamental insights in endothelial metabolism: PFKFB3 drug discovery and development | 2016 |
| 7 | OvaRenew | OvaRenew as a first-line therapy in impaired egg quality treatment | 2016 |
| 8 | anTBiotic | AnTBiotic – progressing TB drug candidates to clinical proof of concept | 2017 |
| 9 | Curtana | Patented small molecule therapeutics that target cancer stem cells for the treatment of glioblastoma and other brain cancers | 2017 |
| 10 | CMI2T IA | Harmless Clostridium bacteria as a highly targeted, continuous delivery system for immunomodulatory anti-cancer drugs | 2017 |
| 11 | ONCOPHAGY | Novel Atg4B-inhibitors and dual [Atg4B-carbonic anhydrase]inhibitors for interfering with cytoprotective mechanisms of cancercells in the acidic tumor micro-environment. | 2017 |
| 12 | Soraprazan | Soraprazan - a new regenerative therapy for Stargardt's disease | 2017 |
| 13 | ProCenDecl | Synthesis and validation of chemical Probes for Centrosome Declustering: development of potent and selective anti-cancer agents. | 2019 |
| 14 | TBNANO | Targeted intracellular delivery of antitubercular agents by functionalized nanocapsules | 2019 |
| 15 | TT4CL | Clinical development of oral oleylphosphocholine as a new drug for the treatment of Old World Cutaneous Leishmaniasis | 2019 |
| 16 | CRUCIATA | Uses and meanings of the word crusade in the late Middle Ages | 2019 |
| 17 | IBL-302 | Inflection Bioscience unique dual mechanism, small molecule, orally available therapeutic targeting major unmet medical needs in breast cancer | 2019 |
| 18 | SPELITEC | Sequence sPecific ELImination of shiga-Toxin E. Coli | 2019 |
| 19 | CYPNASH | Validation of a novel class of cyclophilin inhibitors for the treatment of non-alcoholic steatohepatitis | 2019 |
| 20 | NanoGut | Exploiting the pathophysiology of the gut towards innovative oral peptide delivery strategies | 2020 |
| 21 | Oralis | Oralis, The first oral human insulin treatment for Type 2 Diabetes Mellitus | 2019 |
| 22 | ERA4TB | EUROPEAN REGIMEN ACCELERATOR FOR TUBERCULOSIS | 2020 |